Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Complications of Diabetes Mellitus

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Complications of Diabetes Mellitus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holmes, A; Loscalzo, J; Willoughby, S1
Lithner, F1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Complications of Diabetes Mellitus

ArticleYear
Platelets and cardiovascular disease.
    European journal of cardiovascular nursing, 2002, Volume: 1, Issue:4

    Topics: Blood Platelets; Cardiovascular Diseases; Diabetes Complications; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Smoking

2002

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Complications of Diabetes Mellitus

ArticleYear
Diabetes mellitus and Alzheimer's disease.
    Diabetologia, 1996, Volume: 39, Issue:10

    Topics: Aged; Alzheimer Disease; Cerebrovascular Disorders; Confusion; Dementia, Multi-Infarct; Diabetes Complications; Diabetes Mellitus; Glucose Tolerance Test; Humans; Incidence; Insulin; Platelet Activating Factor; Reference Values; Sweden

1996